H5N1's 700km Reach: First Australian Case Spurs Biotech Vaccine Race
The arrival of H5N1 on Australia's mainland, just 700km from Perth, has galvanized the biotech and pharma sector, as the potential for poultry-to-human transmission intensifies demand for avian and pandemic influenza vaccines, antivirals, and diagnostics.
Source: bendigoadvertiser.com.au · juneesoutherncross.com.au